A new client from the United States initially inquired about our peptide products, planning to order three boxes. The selected products included Retatrutide, MOTS-C, DSIP, and Tesamorelin. During our communication, the client expressed clear concerns about product quality, so we provided them with the Certificates of Analysis (COAs) for the corresponding products. After reviewing the COAs, the client approved the quality data and proactively added one additional box to the original order, bringing the total order to four boxes-one of each of the four products. The entire communication process went smoothly; the client did not raise any additional requests regarding price or delivery time, and payment was arranged immediately after the order was confirmed. Although the order volume was not large, it covered a wide range of product categories. As this was our first collaboration, the client's decision to increase the order from three boxes to four demonstrates that the COAs played a positive role in building trust. Moving forward, we will continue to monitor logistics and gather feedback on the client's usage experience, with the aim of using this order as a starting point to foster a long-term and stable partnership.
business process
DSIP: Multidimensional Biological Effects of an Endogenous Peptide
During the exploration of human physiological mechanisms, the discovery of endogenous bioactive molecules often opens new windows for understanding life processes. Delta sleep-inducing peptide (Delta-Sleep-Inducing Peptide, abbreviated as DSIP) is one such remarkable molecule. Since its discovery in the 1970s, DSIP has undergone a cognitive leap from being initially classified as a "sleep peptide" to being recognized as a multifunctional regulatory factor. Its research trajectory reflects the evolution of life science from linear thinking to systems thinking.
The Path to Discovery: From Rabbit Cerebral Venous Blood to a Nine-Amino Acid Peptide
The research on DSIP began with an inspiring experimental design. The research team from Schoenenberger-Monnier in Switzerland, while stimulating the intralaminar nucleus of the rabbit's thalamus with electricity, isolated a substance with specific physiological activity from the extracorporeal dialysate that collected from the confluence sinus veins. After injecting this dialysate into the recipient rabbits, it could induce sleep-like electroencephalogram patterns dominated by Delta waves and spindle waves on the electroencephalogram, and its effect characteristics were impressive.
With the advancement of separation and purification techniques, researchers eventually determined the chemical nature of this active substance - a linear polypeptide composed of nine amino acid residues, with the sequence: tryptophan - alanine - glycine - glycine - aspartic acid - alanine - serine - glycine - glutamic acid. As this peptide was originally named due to its biological effect of inducing Delta wave sleep, the name "Delta Sleep Inducing Peptide" was thus established.
It is worth noting that DSIP is not an exogenous compound but an endogenous peptide substance naturally existing in various mammals. Subsequent studies have confirmed that DSIP-like immunoreactive substances are widely distributed in the brain, cerebrospinal fluid, and peripheral plasma. This endogenous localization provides important clues for the exploration of its physiological functions - since the organism itself synthesizes this peptide, there must be a biological significance to its existence.
Sleep Regulation: From Classical Functions to an Understanding of New Mechanisms
The earliest known function of DSIP is undoubtedly sleep regulation. In various animal models, DSIP has been shown to promote slow-wave sleep. However, the research on its sleep-promoting effect is not entirely consistent, and this divergence actually reveals the complexity of DSIP's action.
Researchers have gradually come to realize that the sleep-regulating effect of DSIP is not merely a simple "hypnotic" effect, but rather is intertwined at a deeper level with the body's physiological rhythms and neuroendocrine regulation.
DSIP can influence the activity of serotonin-N-acetyltransferase in the pineal gland, and this enzyme itself has a significant circadian rhythm. This discovery extends the role of DSIP from merely "sleep induction" to the dimension of "rhythm regulation".
In fact, DSIP and its phosphorylated analogues have been proven to be able to affect and even generate circadian rhythms even in the absence of external timing factors (such as a continuous light environment).
Regarding the molecular mechanism of the sleep-promoting effect of DSIP, studies suggest that it may be mediated through the 5-hydroxytryptamine system.
Experiments show that methysergide (a 5-hydroxytryptamine receptor antagonist) can block the sleep signs induced by DSIP, suggesting that the effect of DSIP is closely related to the 5-hydroxytryptamine neural pathway.
In recent years, a study on the DSIP fusion peptide (DSIP-CBBBP) further confirmed that DSIP can regulate the levels of various neurotransmitters, including 5-hydroxytryptamine, glutamate, dopamine, and melatonin, and shows a restorative effect on the imbalance of neurotransmitters in the insomnia model.
This indicates that the sleep-regulating function of DSIP may be achieved through multi-dimensional neurochemical regulation.
Neuroprotection and Stress Adaptation
Apart from sleep regulation, the potential of DSIP in neuroprotection and stress adaptation has gradually attracted the attention of researchers. In pathological models such as cerebral ischemia, DSIP has demonstrated protective characteristics. Studies have shown that DSIP can improve the recovery of motor function after focal cerebral ischemia, reduce the infarction volume, and lower the mortality rate in the whole brain ischemia model.
The mechanism of its neuroprotective effect may involve multiple aspects: DSIP can reduce the excessive generation of free radicals in the central nervous system induced by stress, prevent neuronal death under hypoxic conditions, and improve the cerebral blood supply during stress. These findings make DSIP a molecule worthy of attention in the field of neuroprotection research.
In terms of stress adaptation, DSIP exhibits characteristics similar to those of an "adaptive origin". Studies have confirmed that DSIP can reduce the stress-related mortality rate of rats with low stress resistance. Its mechanism of action may involve regulating monoamine oxidase activity through the 5-hydroxytryptamine and adrenergic systems. This stress protection effect suggests that DSIP may be involved in the regulatory network of the body's internal homeostasis and play a buffering role when responding to external challenges.
Endocrine Regulation: The Bridging Role of the Growth Hormone Axis
The impact of DSIP on the endocrine system adds a new dimension to its biological functions. Studies have shown that DSIP is closely associated with the release of growth hormone. In sleep deprivation experiments, after rats were deprived of sleep for 4 hours, the amount of slow-wave sleep and the concentration of plasma growth hormone both significantly increased. This increase could be blocked by intracerebroventricular injection of a specific DSIP antiserum. This result strongly suggests that endogenous DSIP plays a key role in the compensatory response after sleep deprivation, and may be a physiological stimulant linking sleep regulation and growth hormone secretion.
From a broader perspective of endocrine regulation, DSIP has a regulatory effect on various hormone levels. Studies have shown that DSIP can lower the basal level of adrenocorticotropic hormone, while stimulating the secretion of luteinizing hormone as well as the release of growth hormone-releasing hormone and growth hormone. This multiple endocrine regulatory effect suggests that DSIP may act as a node in the neuroendocrine network, participating in coordinating the information exchange between different physiological systems.
Insights and Outlook
The research history of DSIP provides a vivid example for us to understand the complexity of endogenous bioactive peptides.
Starting from a "sleep peptide" discovered based on a specific physiological effect, to the current recognition of it as a multifunctional molecule involved in sleep-wake regulation, neuroprotection, stress adaptation, and endocrine integration, the evolution of DSIP's identity highlights the diversity of molecular functions in the life system.
Of course, many aspects of DSIP still require further exploration.
The molecular identity of its specific receptors, the dynamic changes under different physiological conditions, and its potential application value in various pathological states, are all directions worthy of further investigation.
However, in any case, as a regulatory peptide naturally present in the human body, the study of DSIP not only enriches our understanding of sleep, rhythms, and neuroprotective mechanisms, but also provides a valuable window for understanding how organisms achieve systemic integration through endogenous molecules.
